Upon the occurrence of a Kras mutation, GTP hydrolysis is impaired and/or nucleotide exchange is augmented, resulting in the accumulation of active Kras, which facilitates the persistent activation of downstream signaling pathways, thus increasing tumor cell proliferation (Li et al., 2012; Zhu et al., 2021). The gene discussed is KRAS; the disease is neoplasm.